Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 6/2013

01-06-2013 | Article

Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease

Authors: J. P. Lindahl, A. Hartmann, R. Horneland, H. Holdaas, A. V. Reisæter, K. Midtvedt, T. Leivestad, O. Øyen, T. Jenssen

Published in: Diabetologia | Issue 6/2013

Login to get access

Abstract

Aims/hypothesis

We aimed to determine whether simultaneous pancreas and kidney (SPK) transplantation would improve patient and kidney graft survival in diabetic end-stage renal disease (ESRD) compared with kidney transplantation alone (KTA).

Methods

Follow-up data were retrieved for all 630 patients with diabetic ESRD who had received SPK or KTA at our centre from 1983 to the end of 2010. Recipients younger than 55 years of age received either an SPK (n = 222) or, if available, a single live donor kidney (LDK; n = 171). Older recipients and recipients with greater comorbidity received a single deceased donor kidney (DDK; n = 237). Survival was analysed by the Kaplan–Meier method and in multivariate Cox regression analysis adjusting for recipient and donor characteristics.

Results

Patient survival was superior in SPK compared with both LDK and DDK recipients in univariate analysis. Follow-up time (mean ± SD) after transplantation was 7.1 ± 5.7 years. Median actuarial patient survival was 14.0 years for SPK, 11.5 years for LDK and 6.7 years for DDK recipients. In multivariate analyses including recipient age, sex, treatment modality, time on dialysis and era, SPK transplantation was protective for all-cause mortality compared with both LDK (p = 0.02) and DDK (p = 0.029) transplantation. After the year 2000, overall patient survival improved compared with previous years (HR 0.40, 95% CI 0.30, 0.55; p < 0.001). Pancreas graft survival also improved after 2000, with a 5 year graft survival rate of 78% vs 61% in previous years (1988–1999).

Conclusions/interpretation

Recipients of SPK transplants have superior patient survival compared with both LDK and DDK recipients, with improved results seen over the last decade.
Literature
1.
Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC (1967) Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 61:827–837PubMed
2.
Gruessner AC (2011) 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud 8:6–16PubMedCrossRef
3.
Sutherland DE, Gruessner RW, Dunn DL et al (2001) Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 233:463–501PubMedCrossRef
4.
Sollinger HW, Odorico JS, Becker YT, D'Alessandro AM, Pirsch JD (2009) One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg 250:618–630PubMed
5.
Wolfe RA, Ashby VB, Milford EL et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341:1725–1730PubMedCrossRef
6.
Meier-Kriesche HU, Port FK, Ojo AO et al (2000) Effect of waiting time on renal transplant outcome. Kidney Int 58:1311–1317PubMedCrossRef
7.
Schnuelle P, Lorenz D, Trede M, van Der Woude FJ (1998) Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 9:2135–2141PubMed
8.
Witczak BJ, Hartmann A, Jenssen T, Foss A, Endresen K (2006) Routine coronary angiography in diabetic nephropathy patients before transplantation. Am J Transplant 6:2403–2408PubMedCrossRef
9.
Stratta RJ (1999) Review of immunosuppressive usage in pancreas transplantation. Clin Transplant 13:1–12PubMedCrossRef
10.
Meier-Kriesche HU, Li S, Gruessner RW et al (2006) Immunosuppression: evolution in practice and trends, 1994–2004. Am J Transplant 6:1111–1131PubMedCrossRef
11.
Tyden G, Tollemar J, Bolinder J (2000) Combined pancreas and kidney transplantation improves survival in patients with end-stage diabetic nephropathy. Clin Transplant 14:505–508PubMedCrossRef
12.
Knoll GA, Nichol G (2003) Dialysis, kidney transplantation, or pancreas transplantation for patients with diabetes mellitus and renal failure: a decision analysis of treatment options. J Am Soc Nephrol 14:500–515PubMedCrossRef
13.
Mohan P, Safi K, Little DM et al (2003) Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. Br J Surg 90:1137–1141PubMedCrossRef
14.
Reddy KS, Stablein D, Taranto S et al (2003) Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 41:464–470PubMedCrossRef
15.
Rayhill SC, D'Alessandro AM, Odorico JS et al (2000) Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? Ann Surg 231:417–423PubMedCrossRef
16.
Morath C, Zeier M, Dohler B, Schmidt J, Nawroth PP, Opelz G (2008) Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes. J Am Soc Nephrol 19:1557–1563PubMedCrossRef
17.
Ojo AO, Meier-Kriesche HU, Hanson JA et al (2001) The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 71:82–90PubMedCrossRef
18.
Bunnapradist S, Cho YW, Cecka JM, Wilkinson A, Danovitch GM (2003) Kidney allograft and patient survival in type I diabetic recipients of cadaveric kidney alone versus simultaneous pancreas kidney transplants: a multivariate analysis of the UNOS database. J Am Soc Nephrol 14:208–213PubMedCrossRef
19.
Israni AK, Feldman HI, Propert KJ, Leonard M, Mange KC (2005) Impact of simultaneous kidney-pancreas transplant and timing of transplant on kidney allograft survival. Am J Transplant 5:374–382PubMedCrossRef
20.
Waki K, Terasaki PI (2006) Kidney graft and patient survival with and without a simultaneous pancreas utilizing contralateral kidneys from the same donor. Diabetes Care 29:1670–1672PubMedCrossRef
21.
Young BY, Gill J, Huang E et al (2009) Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database. Clin J Am Soc Nephrol 4:845–852PubMedCrossRef
22.
Weiss AS, Smits G, Wiseman AC (2009) Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation. Clin J Am Soc Nephrol 4:988–995PubMedCrossRef
23.
Huang E, Wiseman A, Okumura S, Kuo HT, Bunnapradist S (2011) Outcomes of preemptive kidney with or without subsequent pancreas transplant compared with preemptive simultaneous pancreas/kidney transplantation. Transplantation 92:1115–1122PubMedCrossRef
24.
Becker BN, Brazy PC, Becker YT et al (2000) Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 57:2129–2135PubMedCrossRef
25.
Smets YF, Westendorp RG, van der Pijl JW et al (1999) Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 353:1915–1919PubMedCrossRef
26.
Norman SP, Kommareddi M, Ojo AO, Luan FL (2011) Early pancreas graft failure is associated with inferior late clinical outcomes after simultaneous kidney-pancreas transplantation. Transplantation 92:796–801PubMedCrossRef
27.
Morath C, Zeier M, Dohler B et al (2010) Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft. Clin J Am Soc Nephrol 5:549–552PubMedCrossRef
28.
Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69–75PubMedCrossRef
29.
Nathan DM, Cleary PA, Backlund JY et al (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653PubMedCrossRef
30.
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577–1589PubMedCrossRef
31.
Luan FL, Miles CD, Cibrik DM, Ojo AO (2007) Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus. Transplantation 84:541–544PubMedCrossRef
32.
Boggi U, Vistoli F, Amorese G et al (2012) Long-term (5 years) efficacy and safety of pancreas transplantation alone in type 1 diabetic patients. Transplantation 93:842–846PubMedCrossRef
33.
Gruessner RW, Sutherland DE, Kandaswamy R, Gruessner AC (2008) Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. Transplantation 85:42–47PubMedCrossRef
34.
Krieger NR, Odorico JS, Heisey DM et al (2003) Underutilization of pancreas donors. Transplantation 75:1271–1276PubMedCrossRef
35.
Smith GC, Trauer T, Kerr PG, Chadban SJ (2010) Prospective quality-of-life monitoring of simultaneous pancreas and kidney transplant recipients using the 36-item short form health survey. Am J Kidney Dis 55:698–707PubMedCrossRef
36.
Hartmann A, Jenssen T, Holdaas H (2012) Diabetes, chronic kidney disease and cancer risk. Nephrol Dial Transplant 27:3018–3020PubMedCrossRef
Metadata
Title
Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease
Authors
J. P. Lindahl
A. Hartmann
R. Horneland
H. Holdaas
A. V. Reisæter
K. Midtvedt
T. Leivestad
O. Øyen
T. Jenssen
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-2888-y

Other articles of this Issue 6/2013

Diabetologia 6/2013 Go to the issue

Commentary

Should more attention be paid to school performance in children and adolescents with diabetes?

Review

Evidence base in guideline generation in diabetes

Article

A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice

Article

Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy

Article

Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels

Systematic Review

Effects of exercise training on quality of life, symptoms of depression, symptoms of anxiety and emotional well-being in type 2 diabetes mellitus: a systematic review

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits